The Journal of Organic Chemistry
Article
80:1) to give 1b in 42% yield (151.6 mg) as a colorless oil. IR (neat):
115.9, 49.2, 39.1, 38.9, 31.5, 29.2, 26.1, 26.0, 19.5, 14.9; HRMS-EI: m/
z [M]+ calcd for C13H23NO, 209.178; found, 209.1778.
1
3075, 1710, 1640, 996, 948 cm−1; H NMR (400 MHz, CDCl3): δ
trans-1-(2-Allylcyclohexyl)pentan-1-one Oxime (2d). From
1d (556.4 mg, 2.67 mmol), the title compound was similarly prepared
as 2a. The reaction proceeded for 22 h at rt. After chromatographic
purification (hexane/EtOAc 30:1, 20:1, 10:1, 5:1), 198 mg of 2d was
obtained (33%) as an isomeric mixture (E/Z = 16/84). IR (neat):
5.76−5.65 (m, 1H), 4.95 (dm, J = 9.4 Hz, 1H), 4.94 (dm, J = 17.8 Hz,
1H), 2.52 (dq, J = 17.9, 7.3 Hz, 1H), 2.36 (dq, J = 17.9, 7.3 Hz, 1H),
2.22 (td, J = 10.7, 2.4 Hz, 1 H), 2.03−1.99 (m, 1H), 1.93−1.65 (m,
7H), 1.32−1.15 (m, 3 H), 1.02 (t, J = 7.3 Hz, 3H); 13C NMR (100
MHz, CDCl3): δ 215.3, 136.6, 116.1, 55.9, 39.4, 38.1, 35.7, 30.9, 30.2,
25.9, 25.7, 7.6; HRMS-EI: m/z [M]+ calcd for C12H20O, 180.1514;
found, 180.1521.
trans-1-(2-Allylcyclohexyl)butan-1-one (1c). The title com-
pound was similarly prepared as 1b from 1a (791.9 mg, 4.76 mmol) by
using iodoethane as the alkylating reagent. The reaction proceeded for
16 h at rt. After chromatographic purification (hexane/EtOAc 250:1,
200:1, 100:1), 509 mg of 1c was obtained (55%) as a yellow oil. IR
(neat): 3075, 1708, 1665, 910, 995 cm−1; 1H NMR (400 MHz,
CDCl3): δ 5.76−5.67 (m, 1H), 4.96 (dm, J = 8.6 Hz, 1H), 4.95 (dm, J
= 17.3 Hz, 1H), 2.46 (dt, J = 17.2, 7.4 Hz, 1H), 2.34 (dt, J = 17.2, 7.2
Hz, 1H), 2.20 (tm, J = 10.1 Hz, 1H), 2.05−2.00 (m, 1H), 1.84−1.67
(m, 6 H), 1.60 (sextet, J = 7.4 Hz, 2H), 1.31−1.13 (m, 3H), 1.02−0.94
(m, 1 H), 0.90 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ
214.8, 136.6, 116.2, 56.1, 44.5, 39.3, 37.9, 30.9, 30.0, 25.9, 25.7, 16.8,
13.8; HRMS-EI: m/z [M]+ calcd for C13H22O, 194.1671; found,
194.1668.
trans-1-(2-Allylcyclohexyl)pentan-1-one (1d). The title com-
pound was similarly prepared as 1b from 1a (716.6 mg, 4.31 mmol) by
using iodopropane as the alkylating reagent. The reaction proceeded
for 21 h at rt. After chromatographic purification (hexane/EtOAc
100:1), 514 mg of 1d was obtained (57%) as a yellow oil. IR (neat):
3074, 1707, 1642, 995, 968, 911 cm−1; 1H NMR (400 MHz, CDCl3):
δ 5.80−5.65 (m, 1H), 4.96 (br d, J = 9.2 Hz, 1H), 4.95 (br d, J = 17.9
Hz, 1H), 2.48 (dt, J = 17.1, 7.5 Hz, 1H), 2.36 (dt, J = 17.1, 7.3 Hz,
1H), 2.21 (tm, J = 10.9 Hz, 1H), 2.05−2.01 (m, 1H), 1.83−1.70 (m,
5H), 1.57−1.49 (m, 2H), 1.35−1.20 (m, 6 H), 0.99−0.94 (m, 1H),
0.90 (t, J = 7.32 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 214.9,
136.6, 116.2, 56.1, 42.3, 39.3, 37.9, 30.9, 30.1, 25.9, 25.7, 25.5, 22.4,
13.9; HRMS-EI: m/z [M]+ calcd for C14H24O, 208.1827; found,
208.1832.
1
3266, 1642, 1448, 1101, 993, 951, 911 cm−1; H NMR (400 MHz,
CDCl3) δ E-form: 9.39 (br s, 1H), 5.83−5.61 (m, 1H), 4.99 (dm, J =
10.9 Hz, 2H), 2.38 (dt, J = 17.8, 5.2 Hz, 1H), 2.36−2.31 (m, 1H),
2.24−2.02 (m, 1H), 2.00−1.82 (m, 2H), 1.80−1.61 (m, 4H), 1.60−
1.44 (m, 3H), 1.43−1.31 (m, 3H), 1.30−1.15 (2H), 1.01−0.85 (m,
1H), 0.92 (t, J = 8.0 Hz, 3H); Z-form: 8.96 (br s,, 1H), 5.83−5.61 (m,
1H), 4.96 (dm, J = 11.8 Hz, 2H), 2.15 (dt, J = 21.9, 8.6 Hz, 1H),
2.23−2.02 (m, 2H), 1.99−1.83 (m, 2H), 1.80−1.69 (m, 4H), 1.60−
1.45 (m, 3H), 1.44−1.30 (m, 3H), 1.29−1.15 (m, 2H), 1.01−0.83 (m,
1H), 0.93 (t, J = 7.04 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ E-
form:163.1, 137.0, 115.8, 49.2, 39.1, 38.4, 31.6, 31.6, 29.2, 26.9, 26.2,
25.8, 22.7, 13.9; Z-form: 164.2, 136.9 115.9, 49.2, 39.1, 38.9, 31.6, 31.6,
28.3, 28.1, 26.1, 26.0, 23.5, 13.8; HRMS-EI: m/z [M]+ calcd for
C14H25NO, 223.1936; found, 223.1936.
General Procedure for Preparing 3b−d; trans-Diethyl-1-(2-
allylcyclohexyl)propylideneaminooxyphosphonate (3b). Under
N2 protection, sodium hydride (50.6 mg, 60%, 1.26 mmol) and diethyl
chlorophosphate (0.31 mL, 2.11 mmol) were successively added to a
solution of 2b (102.9 mg, 0.527 mmol) in THF (6.4 mL) precooled at
0 °C. The mixture was stirred at rt for 20 h, then diluted by EtOAc
(150 mL), and washed with saturated NH4Cl aqueous solution (20
mL), water (20 mL × 2) and brine (20 mL). After concentration, the
crude mixture was purified by chromatography (hexane/EtOAc 8:1,
5:1, 2:1, 1:1) to afford 3b (146 mg, 84%, E/Z = 57/43) as a colorless
oil. IR (neat): 3076, 1640, 1548, 1274, 1034, 974, 910 cm−1; 1H NMR
(400 MHz, CDCl3) δ E-form: 5.79−5.66 (m, 1H), 4.98 (dm, J = 10.0
Hz, 1H), 4.97 (dm, J = 17.2 Hz, 1H); 4.29−4.11 (m, 4H); 2.48 (dq, J
= 13.9, 7.7 Hz, 1H) 2.34−2.25 (m, 2H), 2.25−1.97 (m, 3H), 1.94−
1.82 (m, 1H), 1.82−1.48 (m, 5H), 1.35 (t, J = 7.04 Hz, 6H), 1.29−
1.18 (m, 1H), 1.14 (t, J = 7.2 Hz, 3H), 1.04−0.88 (m, 1H); Z-form:
5.79−5.66 (m, 1H); 4.98 (dm, J = 10.0 Hz, 1H); 4.97 (dm, J = 17.2
Hz, 1H); 4.29−4.11 (m, 4H), 2.37−2.30 (m, 1H); 2.34−2.25 (m,
2H), 2.25−1.97 (m, 3H), 1.94−1.82 (m, 1H), 1.82−1.48 (m, 5H),
1.35 (t, J = 7.04 Hz, 6H), 1.29−1.18 (m, 1H), 1.14 (t, J = 7.2 Hz, 3H),
1.04−0.88 (m, 1H); 13C NMR (100 MHz, CDCl3) δ E-form: 172.5 (d,
trans-1-(2-Allylcyclohexyl)propan-1-one Oxime (2b). From
1b (240.2 mg, 1.33 mmol), the title compound was similarly prepared
as 2a. The reaction proceeded for 20 h at rt. After chromatographic
purification (hexane/EtOAc 40:1, 20:1, 10:1), 106.7 mg of 2b was
obtained (41%) as an isomeric mixture (E/Z = 60:40). IR (neat):
JC−P = 12.1 Hz), 136.3, 116.3, 64.3 (d, JC−P = 3.9 Hz), 64.2 (d, JC−P
=
1
3247, 3079, 1640, 996, 914 cm−1; H NMR (400 MHz, CDCl3) δ E-
6.2 Hz), 48.8, 39.1, 38.4, 31.4, 31.3, 29.4, 25.9, 25.8, 21.0, 16.2 (d, JC−P
= 6.3 Hz), 10.6; Z-form: 173.7 (d, JC−P = 11.9 Hz), 136.2, 116.2, 64.4
(d, JC−P = 4.7 Hz), 64.3 (d, JC−P = 3.9 Hz), 48.8, 38.8, 38.6, 31.0, 30.9,
29.4, 25.8, 25.7, 21.0, 16.2 (d, JC−P = 6.3 Hz), 10.9; HRMS-EI: m/z
[M]+ calcd for C16H30NO4P, 331.1912; found, 331.1904.
form: 9.33 (br s, 1H), 5.81−5.68 (m, 1H), 4.97−4.94 (m, 2H), 2.41
(dq, J = 16.0, 8.0 Hz, 1H) 2.29−2.12 (m, 2H) 2.09−1.92 (m, 1H);
1.91−1.83 (m, 1H), 1.82−1.61 (m, 4H), 1.61−1.18 (m, 4H), 1.11 (t, J
= 7.4 Hz, 3H), 1.01−0.80 (m, 1H); Z-form: 9.60 (br s, 1H), 5.72−5.64
(m, 1H), 5.00−4.92 (m, 2H), 2.40−2.32 (m, 1H), 2.29−2.12 (m, 2H),
2.09−1.92 (m, 1H), 1.91−1.83 (m, 1H), 1.82−1.61 (m, 4H), 1.61−
1.18 (m, 4H), 1.13 (t, J = 7.6 Hz, 3H), 1.01−0.80 (m, 1H); 13C NMR
(100 MHz, CDCl3) δ E-form: 163.8, 137.0, 115.8, 49.2, 39.1, 38.9,
31.6, 31.4, 26.2, 26.0, 20.0, 10.5; Z-form: 165.0, 136.8, 116.0, 49.2,
38.9, 38.5, 31.6, 31.4, 26.1, 26.0, 20.0, 10.5; HRMS-EI: m/z [M]+ calcd
for C12H21NO, 195.1623; found, 195.1616.
t r a n s - D i e t h y l - 1 - ( 2 - a l l y l c y c l o h e x y l ) -
butylideneaminooxyphosphonate (3c). From 2c (37.9 mg, 0.18
mmol), the title compound was similarly synthesized as 3b. The
reaction proceeded for 18 h at rt. After chromatographic purification
(hexane/EtOAc 10:1, 5:1, 1:1), 3c (53.2 mg, 85%, E/Z = 40/60) was
obtained as a pale yellow oil. IR (neat): 3075, 1662, 1640, 1274, 1035,
979, 927 cm−1; 1H NMR (400 MHz, CDCl3) δ E-form: 5.79−5.66 (m,
1H), 4.97 (dm, J = 9.6 Hz, 1H), 4.96 (dm, J = 17.6 1H), 4.28−4.11
(m, 4H), 2.42 (dt, J = 17.9, 5.4 Hz, 1H), 2.16−2.08 (m, 2H), 2.08−
2.08−1.83 (m, 3H), 1.83−1.51 (m, 7H), 1.35 (t, J = 7.04 Hz, 6H),
1.29−1.14 (m, 1H), 0.95 (t, J = 7.32 Hz, 3H), 0.91−0.83 (m, 1H); Z-
form: 5.79−5.66 (m, 1H), 4.97 (dm, J = 9.6 Hz, 1H), 4.96 (dm, J =
17.6 1H), 4.28−4.11 (m, 4H), 2.22 (dt, J = 15.4, 7.9 Hz, 1H), 2.16−
2.08 (m, 2H), 2.08−1.83 (m, 3H), 1.83−1.51 (m, 7H), 1.35 (t, J =
7.04 Hz, 6H), 1.29−1.14 (m, 1H), 0.97 (t, J = 7.24 Hz, 3H), 0.91−
0.83 (m, 1H); 13C NMR (100 MHz, CDCl3) δ E-form: 171.4 (d, JC−P
= 12.2 Hz), 136.3, 116.3, 64.2 (d, JC−P = 5.9 Hz), 48.8, 38.7, 38.3, 31.3,
31.1, 29.2, 25.9, 25.7, 19.4, 16.1 (d, JC−P = 6.3 Hz), 14.0; Z-form: 172.7
(d, JC−P = 11.8 Hz), 136.3, 116.3; 64.3 (d, JC−P = 5.9 Hz), 48.8, 39.1,
38.8, 31.4, 31.1, 30.1, 25.8, 25.8, 19.9, 16.1 (d, JC−P = 6.3 Hz), 14.8;
HRMS-EI: m/z [M]+ calcd for C17H32NO4P, 345.2069; found,
345.2061.
trans-1-(2-Allylcyclohexyl)butan-1-one Oxime (2c). From 1c
(266.3 mg, 1.37 mmol), the title compound was similarly prepared as
2a. The reaction proceeded for 24 h at rt. After chromatographic
purification (hexane/EtOAc 30:1, 20:1, 10:1, 5:1), 117 mg of 2c was
obtained (40%) as an isomeric mixture (E/Z = 46/54). IR (neat):
1
3579, 3100, 1640, 993, 909 cm−1; H NMR (400 MHz, CDCl3) δ E-
form: 8.36 (br s, 1H), 5.81−5.68 (m, 1H), 4.97 (dm, J = 10.8 Hz, 2H),
2.36−2.32 (m, 1H), 2.22−2.01 (m, 2H), 1.98−1.83 (m, 2H), 1.83−
1.68 (m, 4H), 1.68−1.45 (m, 4H), 1.37−1.11 (m, 2H), 0.95 (t, J = 7.4
Hz, 3H), 0.95−0.85 (m, 1H); Z-form: 8.14 (br s, 1H), 5.81−5.68 (m,
1H), 4.97 (dm, J = 10.8 Hz, 2H), 2.35 (dt, J = 18.0, 6.8 Hz, 1H),
2.22−2.01 (m, 2H), 1.98−1.83 (m, 2H), 1.83−1.68 (m, 4H), 1.68−
1.45 (m, 4H), 1.37−1.11 (m, 2H), 0.98 (t, J = 7.3 Hz, 3H), 0.95−0.85
(m, 1H); 13C NMR (100 MHz, CDCl3) δ E-form: 163.0, 137.0, 115.9,
49.2, 39.1, 38.4, 31.6, 29.2, 26.1, 25.9, 19.5,14.2; Z-form: 164.3, 136.9,
3631
dx.doi.org/10.1021/jo5005422 | J. Org. Chem. 2014, 79, 3623−3633